Zomedica Corp. [AMEX: ZOM] stock went on an upward path that rose over 1.26% on Tuesday, amounting to a one-week price increase of more than 2.77%. The company report on August 15, 2023 at 10:20 AM that Sidoti Events, LLC’s Virtual August Micro-Cap Conference.
Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com
Over the last 12 months, ZOM stock dropped by -30.34%. The average equity rating for ZOM stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $187.52 million, with 979.95 million shares outstanding and 966.01 million shares in the current float. Compared to the average trading volume of 4.21M shares, ZOM stock reached a trading volume of 3389676 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Zomedica Corp. [ZOM]:
Dawson James have made an estimate for Zomedica Corp. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp. is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 8.37. The Price to Book ratio for the last quarter was 0.71, with the Price to Cash per share for the same quarter was set at 0.13.
ZOM Stock Performance Analysis:
Zomedica Corp. [ZOM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.77. With this latest performance, ZOM shares dropped by -11.76% in over the last four-week period, additionally sinking by -22.89% over the last 6 months – not to mention a drop of -30.34% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 41.30, with the RSI for the last a single of trading hit 40.22, and the three-weeks RSI is set at 42.83 for Zomedica Corp. [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.2040, while it was recorded at 0.1870 for the last single week of trading, and 0.2150 for the last 200 days.
Insight into Zomedica Corp. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Zomedica Corp. [ZOM] shares currently have an operating margin of -115.81 and a Gross Margin at +50.77. Zomedica Corp.’s Net Margin is presently recorded at -89.88.
Return on Total Capital for ZOM is now -8.10, given the latest momentum, and Return on Invested Capital for the company is -6.30. Return on Equity for this stock declined to -6.32, with Return on Assets sitting at -6.08. When it comes to the capital structure of this company, Zomedica Corp. [ZOM] has a Total Debt to Total Equity ratio set at 0.65. Additionally, ZOM Total Debt to Total Capital is recorded at 0.65, with Total Debt to Total Assets ending up at 0.62. Long-Term Debt to Equity for the company is recorded at 0.41, with the Long-Term Debt to Total Capital now at 0.41.
Reflecting on the efficiency of the workforce at the company, Zomedica Corp. [ZOM] managed to generate an average of -$200,176 per employee. Receivables Turnover for the company is 14.40 with a Total Asset Turnover recorded at a value of 0.07.Zomedica Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.90 and a Current Ratio set at 19.40.
Zomedica Corp. [ZOM] Institutonal Ownership Details
The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 1.31 billion shares, which is approximately 8.2089%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $170.67 trillion in ZOM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $150.98 trillion in ZOM stock with ownership which is approximately 5.7381%.